Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-020792
Filing Date
2017-11-01
Accepted
2017-11-01 16:19:57
Documents
67
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fmi-10q_20170930.htm 10-Q 1647379
2 EX-31.1 fmi-ex311_9.htm EX-31.1 15722
3 EX-31.2 fmi-ex312_6.htm EX-31.2 15533
4 EX-32.1 fmi-ex321_7.htm EX-32.1 5573
  Complete submission text file 0001564590-17-020792.txt   5940042

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT fmi-20170930.xml EX-101.INS 1291799
6 XBRL TAXONOMY EXTENSION SCHEMA fmi-20170930.xsd EX-101.SCH 44771
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fmi-20170930_cal.xml EX-101.CAL 41769
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fmi-20170930_def.xml EX-101.DEF 141089
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fmi-20170930_lab.xml EX-101.LAB 335763
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fmi-20170930_pre.xml EX-101.PRE 256577
Mailing Address 150 SECOND STREET CAMBRIDGE MA 02141
Business Address 150 SECOND STREET CAMBRIDGE MA 02141 617-418-2200
Foundation Medicine, Inc. (Filer) CIK: 0001488613 (see all company filings)

EIN.: 271316416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36086 | Film No.: 171169198
SIC: 8071 Services-Medical Laboratories